Pavmed Rg

PAVmed Inc. develops cutting‑edge, single‑use devices for early detection and treatment of carpal tunnel syndrome and esophageal premalignancy, including its patented CarpX and EsoCheck, targeting high‑value unmet medical needs.

Headquarters: United States (USA)

Pavmed Rg Logo
Company Profile
  • Employees: 39
  • HQ: New York
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
PAVM Pavmed Rg
Cap: 0.0B
EQUITY NMS USD US70387R1068 Active
📈
Home Login